Orca Bio
43 open jobs
National Senior Director, Field Medical Affairs
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto National Senior Director, Field Medical Affairs at Orca Bio seen live 1 day ago posted 2 days agoCoordinator, Commercial Marketing and MLR
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Medical Science Liaison - Great Lakes (IL, MI, MO, MN, WI, IN, IA, ND, SD)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Medical Science Liaison - Great Lakes (IL, MI, MO, MN, WI, IN, IA, ND, SD) at Orca Bio seen live 1 day ago posted 5 days agoPayer Account Director - Southeast
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Manager, Quality Assurance - East Coast (Princeton, NJ)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease.
Applyto Manager, Quality Assurance - East Coast (Princeton, NJ) at Orca Bio seen live 1 day ago posted 12 days agoDirector of Trade, Distribution and Patient Assistance
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Director of Trade, Distribution and Patient Assistance at Orca Bio seen live 1 day ago posted 16 days agoSenior Director/Head, Field Market Access
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Senior Director/Head, Field Market Access at Orca Bio seen live 1 day ago posted 16 days agoClinical Research Associate
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
General Manager, Commercial Manufacturing Facility
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto General Manager, Commercial Manufacturing Facility at Orca Bio seen live 1 day ago posted 26 days agoDirector/Head, Pharmacovigilance
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Medical Science Liaison - Ohio Valley (OH, PA, IN, KY, MD, VA, WV, DE)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Medical Science Liaison - Ohio Valley (OH, PA, IN, KY, MD, VA, WV, DE) at Orca Bio seen live 1 day ago posted 32 days agoProject Manager - Project Management Office (PMO)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Project Manager - Project Management Office (PMO) at Orca Bio seen live 1 day ago posted 32 days agoSupervisor, Quality Assurance (Swing Shift)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Supervisor, Quality Assurance (Swing Shift) at Orca Bio seen live 1 day ago posted 35 days agoSpecialist I, Quality Assurance
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Director, Cell Therapy Case Management
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Associate, Pharmacovigilance Operations/Drug Safety
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Associate, Pharmacovigilance Operations/Drug Safety at Orca Bio seen live 1 day ago posted 40 days agoSenior Manager / Associate Director, Gross-to-Net & Revenue Planning
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Senior Manager / Associate Director, Gross-to-Net & Revenue Planning at Orca Bio seen live 1 day ago posted 47 days agoHead of Business Development
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Manufacturing Systems and Master Data Administrator
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Manufacturing Systems and Master Data Administrator at Orca Bio seen live 1 day ago posted 51 days agoOperations Supervisor, Logistics & Cold Chain
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Operations Supervisor, Logistics & Cold Chain at Orca Bio seen live 1 day ago posted 53 days agoSenior Engineer, Process Validation - Cell Therapy
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Senior Engineer, Process Validation - Cell Therapy at Orca Bio seen live 1 day ago posted 55 days agoSpecialist, Logistics (Night Shift)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Statistician, CMC (Chemistry, Manufacturing, and Controls)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Statistician, CMC (Chemistry, Manufacturing, and Controls) at Orca Bio seen live 1 day ago posted 61 days agoSpecialist, Facilities
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Senior Director, Regulatory Affairs
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Scientist, Quality Control (2nd/3rd Shift)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Scientist, Quality Control (2nd/3rd Shift) at Orca Bio seen live 1 day ago posted 76 days agoManufacturing Process Lead (3rd Shift)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Manufacturing Sciences and Technology (MSAT) Process Engineer (3rd Shift)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Manufacturing Sciences and Technology (MSAT) Process Engineer (3rd Shift) at Orca Bio seen live 1 day ago posted 76 days agoSpecialist, IT & Manufacturing Systems Support (Off-Shift)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Specialist, IT & Manufacturing Systems Support (Off-Shift) at Orca Bio seen live 1 day ago posted 97 days agoChief of Staff to CEO and President
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Supervisor, Commercial Manufacturing - Day Shift
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Supervisor, Commercial Manufacturing - Day Shift at Orca Bio seen live 1 day ago posted 123 days agoSenior Manager, Facilities
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Technician, Quality Control - Day Shift
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Associate, Cell Therapy Production, 3rd Shift
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Associate, Cell Therapy Production, 3rd Shift at Orca Bio seen live 1 day ago posted 191 days agoCalibration Technician
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Specialist, Environment, Health & Safety
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Specialist, Environment, Health & Safety at Orca Bio seen live 1 day ago posted 209 days agoTechnician, Quality Control - Night Shift
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Technician, Quality Control - Night Shift at Orca Bio seen live 1 day ago posted 212 days agoTechnician, Facilities/Maintenance - Night Shift
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Technician, Facilities/Maintenance - Night Shift at Orca Bio seen live 1 day ago posted 212 days agoAssociate, Packaging Operations and Cold Chain Handling - Night Shift
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Associate, Packaging Operations and Cold Chain Handling - Night Shift at Orca Bio seen live 1 day ago posted 212 days agoCell Therapy Production Associate, Oncology - Day Shift (Multiple Positions)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Cell Therapy Production Associate, Oncology - Day Shift (Multiple Positions) at Orca Bio seen live 1 day ago posted 219 days agoCell Therapy Production Associate, Oncology - Night Shift (Multiple Positions)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Cell Therapy Production Associate, Oncology - Night Shift (Multiple Positions) at Orca Bio seen live 1 day ago posted 219 days agoSupervisor, Commercial Manufacturing - Night Shift
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio
Applyto Supervisor, Commercial Manufacturing - Night Shift at Orca Bio seen live 1 day ago posted 461 days agoJoin Our Talent Community
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio